This study is looking at a special imaging agent called [11C]SY08. Researchers want to see how this agent moves through the brain and if it can help detect alpha synuclein (αS) aggregates, which are clumps of protein linked to certain brain conditions. This is being studied in people with Parkinson's disease (PD), Multiple System Atrophy (MSA), Dementia with Lewy Bodies (DLB), and healthy volunteers. The main goal is to understand how [11C]SY08 works in the brain. You may be able to join if you are between 50 and 80 years old, can speak English, and can give your consent. The study plans to enroll 40 participants.

Study design

This interventional study plans to enroll 40 participants, including those with Parkinson's disease, Multiple System Atrophy, Dementia with Lewy Bodies, and healthy controls.

What's involved

The study involves evaluating brain uptake of [11C]SY08, measured at up to 120 minutes.

Compensation

Not stated in the trial record.

Follow-up

Brain uptake of the imaging agent will be evaluated for up to 120 minutes.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.